simendan has been researched along with Hypertension, Pulmonary in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (31.25) | 29.6817 |
| 2010's | 25 (52.08) | 24.3611 |
| 2020's | 8 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Xie, W; Yan, W; Zang, H | 1 |
| Hu, Y; Lu, C; Wei, Z; Zeng, Z; Zhang, C | 1 |
| Kittleson, M; Masarone, D; Pacileo, G; Pollesello, P; Tedford, RJ | 1 |
| Dresbach, T; Geipel, A; Holcher, S; Kipfmueller, F; Leyens, J; Mueller, A; Schroeder, L; Strizek, B | 1 |
| Braunschweig, T; Bünting, NA; Kalverkamp, S; Martin, C; Rieg, AD; Schälte, G; Schnöring, H; Schröder, T; Spillner, J; Suleiman, S; Uhlig, S; Verjans, E; von Stillfried, S | 1 |
| Amorim, S; Leite-Moreira, AF; Lourenço, AP; Maciel, MJ; Pinto, R; Saraiva, F; Silva, JC; Tavares-Silva, M | 1 |
| Abdelbaser, I; Elfayoumy, SI; Elgamal, MF; Elmorsy, MM; Mageed, NA; Taman, HI | 1 |
| Borlaug, BA; Brener, MI; Burkhoff, D; Hamid, NB; Rich, S; Shah, SJ; Sunagawa, K | 1 |
| Andersen, A; Bogaard, HJ; Hansen, MS; Happé, C; Holmboe, S; Nielsen-Kudsk, JE; Ringgaard, S; Schultz, JG; Simonsen, U | 1 |
| Alaa, M; Leite, S; Leite-Moreira, AF; Lopes, L; Lourenço, AP; Oliveira-Pinto, J; Tavares-Silva, M | 1 |
| Gong, SG; He, J; Jiang, R; Liu, JM; Luo, CJ; Qiu, HL; Wang, L; Wu, WH; Yuan, P; Zhang, R; Zhao, QH | 1 |
| Gandham, R; Kaur, P; Kundra, TS; Manjunatha, N; Prabhakar, V | 1 |
| Kleinsasser, A; Knotzer, H; Kotzinger, O; Poidinger, B; Rützler, K; Zierer, A | 1 |
| Elhassan, A; Essandoh, M | 1 |
| Sharma, V; Tempe, DK | 1 |
| Bagalas, V; Boutou, AK; Paspala, A; Pitsiou, G; Stanopoulos, I | 1 |
| Ammirati, E; Cipriani, M; Frigerio, M; Garascia, A; Martinelli, L; Moreo, A; Musca, F; Oliva, F; Pacher, V; Verde, A | 1 |
| Boysan, E; Cicekcioglu, F; Ersoy, O; Katircioglu, F; Unal, EU; Yay, K; Yener, U | 1 |
| Aleixandre, L; Cortell, J; Herrera, P; Loro, JM; Valera, F; Vicente, R | 1 |
| Rabanal, JM; Real, MI; Williams, M | 1 |
| Carollo, C; Feltracco, P; Ori, C | 1 |
| Arya, VK; Dutta, V; Kumar, B; Mishra, A; Mishra, AK | 1 |
| Bertram, H; Görler, H; Happel, CM; Hitz, MP; Köditz, H; Wessel, A; Yelbuz, TM | 1 |
| Bollmann, T; Borst, MM; Costard-Jäckle, A; Ewert, R; Kivikko, M; Kleber, FX; Petterson, T; Pohjanjousi, P; Sonntag, S; Wikström, G | 1 |
| Cicekcioglu, F; Ersoy, O; Hijazi, A; Katircioglu, SF; Parlar, AI; Yay, K | 1 |
| Ata, N; Beyaztas, A; Birdane, A; Cavusoglu, Y | 2 |
| Yalta, K; Yilmaz, MB; Yontar, OC | 1 |
| Baddour, AJ; Tagarakis, GI; Tsilimingas, NB | 1 |
| Bendall, J; Chew, MS; Hawthorne, WJ; Huang, S; McLean, A; Simond, D; Ting, I; Whereat, S | 1 |
| Babelova, A; Brandes, RP; Buerkl, J; Hofstetter, C; Kirschning, T; Mieth, A; Neofitidou, S; Revermann, M; Schermuly, RT; Schloss, M; Schröder, K | 1 |
| Bersani, I; Conti, G; De Carolis, MP; De Rosa, G; Pardeo, M; Piastra, M; Romagnoli, C; Stival, E; Tempera, A | 1 |
| Allegaert, K; Thewissen, L | 1 |
| Kylhammar, D; Rådegran, G; Wiklund, A | 1 |
| Marino, P; Meryon, IC | 1 |
| Arkhipova, OA; Chazova, IE; Danilov, NM; Kobal', EA; Martyniuk, TV | 1 |
| Ebade, AA; Khalil, MA; Mohamed, AK | 1 |
| Ewert, P; Hetzer, R; Lange, PE; Luther, YC; Mühler, EG; Nasseri, B; Redlin, M; Schulze-Neick, I; Stiller, B | 1 |
| Ewert, P; Hetzer, R; Lange, PE; Lehmkuhl, HB; Luther, YC; Schulze-Neick, I | 1 |
| Morais, RJ | 1 |
| Carbone, I; Conti, G; De Gaetano, A; Maggiore, SM; Morelli, A; Orecchioni, A; Picchini, U; Pietropaoli, P; Rocco, M; Teboul, JL; Tritapepe, L; Vieillard-Baron, A; Westphal, M | 1 |
| Carlson, RW; Emmans, L | 1 |
| Brimioulle, S; Demester, JP; Fesler, P; Huez, S; Kerbaul, F; Naeije, R; Rondelet, B | 1 |
| Missant, C; Rex, S; Segers, P; Wouters, PF | 1 |
| Morelli, A; Van Aken, H; Westphal, M | 1 |
| Brimioulle, S; Collart, F; Fesler, P; Gariboldi, V; Giorgi, R; Gouin, F; Guieu, R; Kerbaul, F; Mekkaoui, C | 1 |
| Thomas, M | 1 |
| Rabasseda, X | 1 |
3 review(s) available for simendan and Hypertension, Pulmonary
| Article | Year |
|---|---|
The effect of levosimendan on right ventricular function in patients with heart dysfunction: a systematic review and meta-analysis.
Topics: Aged; Cardiac Output; Cardiotonic Agents; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Simendan; Systole; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Right; Ventricular Function, Right | 2021 |
Use of Levosimendan in Patients with Pulmonary Hypertension: What is the Current Evidence?
Topics: Cardiotonic Agents; Humans; Hydrazones; Hypertension, Pulmonary; Pyridazines; Simendan; Vasodilator Agents | 2023 |
Perioperative management of pulmonary hypertension during lung transplantation (a lesson for other anaesthesia settings).
Topics: Anesthesia, General; Cardiotonic Agents; Constriction; Disease Management; Drug Therapy, Combination; Eicosanoids; Extracorporeal Membrane Oxygenation; Heart Atria; Hemodynamics; Humans; Hydrazones; Hypertension, Pulmonary; Intraoperative Complications; Lung Transplantation; Monitoring, Intraoperative; Nitric Oxide Donors; One-Lung Ventilation; Operative Time; Phosphodiesterase Inhibitors; Postoperative Complications; Preanesthetic Medication; Pulmonary Artery; Pyridazines; Respiration, Artificial; Simendan; Vasodilator Agents | 2014 |
8 trial(s) available for simendan and Hypertension, Pulmonary
| Article | Year |
|---|---|
The direct comparison of inhaled versus intravenous levosimendan in children with pulmonary hypertension undergoing on-cardiopulmonary bypass cardiac surgery: A randomized, controlled, non-inferiority study.
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Egypt; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Prospective Studies; Simendan | 2021 |
The Effect of Inhaled Milrinone Versus Inhaled Levosimendan in Pulmonary Hypertension Patients Undergoing Mitral Valve Surgery - A Pilot Randomized Double-Blind Study.
Topics: Administration, Inhalation; Adult; Blood Pressure; Cardiotonic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Male; Milrinone; Mitral Valve; Pilot Projects; Prospective Studies; Pulmonary Wedge Pressure; Simendan; Treatment Outcome; Vascular Resistance | 2018 |
Effectiveness of prophylactic levosimendan in high-risk valve surgery patients.
Topics: Arterial Pressure; Cardiopulmonary Bypass; Cardiovascular Agents; Drug Administration Schedule; Familial Primary Pulmonary Hypertension; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Hydrazones; Hypertension, Pulmonary; Infusions, Parenteral; Pulmonary Artery; Pyridazines; Severity of Illness Index; Simendan; Stroke Volume; Time Factors; Treatment Outcome; Turkey; Vascular Resistance | 2013 |
Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
Topics: Adult; Aortic Valve; Arterial Pressure; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Hypertension, Pulmonary; Male; Middle Aged; Milrinone; Mitral Valve; Norepinephrine; Postoperative Care; Prospective Studies; Pulmonary Artery; Pyridazines; Simendan; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Left | 2016 |
Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot study.
Topics: Double-Blind Method; Female; Hemodynamics; Humans; Hydrazones; Hypertension, Pulmonary; Male; Middle Aged; Pilot Projects; Pyridazines; Simendan; Vasodilator Agents | 2009 |
Levosimendan attenuates pulmonary vascular remodeling.
Topics: Airway Remodeling; Animals; Cardiotonic Agents; Disease Models, Animal; Germany; Glyburide; Hydrazones; Hypertension, Pulmonary; Hypoglycemic Agents; Myocardial Contraction; Nicorandil; Potassium Channels; Pulmonary Circulation; Pyridazines; Rats; Rats, Sprague-Dawley; Simendan; Vasodilator Agents | 2011 |
Levosimendan is superior to dobutamine as an inodilator in the treatment of pulmonary hypertension for children undergoing cardiac surgery.
Topics: Blood Pressure; Cardiac Output; Cardiac Surgical Procedures; Cardiotonic Agents; Child, Preschool; Dobutamine; Female; Humans; Hydrazones; Hypertension, Pulmonary; Infant; Male; Prospective Studies; Pulmonary Artery; Pyridazines; Simendan | 2013 |
Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study.
Topics: Aged; Female; Humans; Hydrazones; Hypertension, Pulmonary; Infusions, Intravenous; Male; Oxygen; Pilot Projects; Prospective Studies; Pyridazines; Respiratory Distress Syndrome; Shock, Septic; Simendan; Stroke Volume; Systole; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Right | 2006 |
37 other study(ies) available for simendan and Hypertension, Pulmonary
| Article | Year |
|---|---|
Comment on "The direct comparison of inhaled versus intravenous levosimendan in children with pulmonary hypertension undergoing on-cardiopulmonary bypass cardiac surgery: A randomized, controlled, non-inferiority study".
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Child; Humans; Hypertension, Pulmonary; Simendan; Vascular Resistance | 2022 |
Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension.
Topics: Adult; Calcium; Cardiac Output, Low; Cardiotonic Agents; Child; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Infant, Premature; Lactates; Simendan; Ventricular Dysfunction, Left | 2023 |
Levosimendan reduces segmental pulmonary vascular resistance in isolated perfused rat lungs and relaxes human pulmonary vessels.
Topics: Animals; Female; Humans; Hypertension, Pulmonary; Lung; Male; Perfusion; Pulmonary Artery; Pulmonary Veins; Rats; Rats, Wistar; Simendan; Vascular Resistance | 2020 |
Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates.
Topics: Administration, Inhalation; Heart Transplantation; Humans; Hypertension, Pulmonary; Iloprost; Simendan | 2021 |
Changes in Stressed Blood Volume with Levosimendan in Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction: Insights Regarding Mechanism of Action From the HELP Trial.
Topics: Blood Volume; Heart Failure; Humans; Hypertension, Pulmonary; Simendan; Stroke Volume | 2021 |
Levosimendan Prevents and Reverts Right Ventricular Failure in Experimental Pulmonary Arterial Hypertension.
Topics: Animals; Cardiac Output; Cardiotonic Agents; Heart Failure; Hemodynamics; Hydrazones; Hypertension, Pulmonary; Male; Pyridazines; Rats; Rats, Sprague-Dawley; Simendan; Ventricular Dysfunction, Right | 2017 |
Dose-Response Head-to-Head Comparison of Inodilators Dobutamine, Milrinone, and Levosimendan in Chronic Experimental Pulmonary Hypertension.
Topics: Animals; Calcium; Chronic Disease; Dobutamine; Dose-Response Relationship, Drug; Hemodynamics; Hydrazones; Hypertension, Pulmonary; Male; Milrinone; Pyridazines; Rats; Rats, Wistar; Simendan | 2017 |
Efficacy and safety of a calcium sensitizer, levosimendan, in patients with right heart failure due to pulmonary hypertension.
Topics: Acute Disease; Adolescent; Adult; Aged; Cardiotonic Agents; China; Dose-Response Relationship, Drug; Heart Failure; Humans; Hydrazones; Hypertension, Pulmonary; Injections, Intravenous; Middle Aged; Prospective Studies; Pulmonary Wedge Pressure; Pyridazines; Receptors, Calcium-Sensing; Simendan; Survival Rate; Treatment Outcome; Ventricular Function, Right; Young Adult | 2018 |
Intravenous Levosimendan and Vasopressin in New-Onset Acute Pulmonary Hypertension After Weaning from Cardiopulmonary Bypass.
Topics: Acute Disease; Aged; Aged, 80 and over; Arterial Pressure; Cardiopulmonary Bypass; Cardiotonic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Injections, Intravenous; Male; Retrospective Studies; Simendan; Treatment Outcome; Vascular Resistance; Vasoconstrictor Agents; Vasopressins | 2019 |
Inhaled Levosimendan for Pulmonary Hypertension Treatment During Cardiac Surgery: A Novel Application to Avoid Systemic Hypotension.
Topics: Double-Blind Method; Humans; Hypertension, Pulmonary; Hypotension; Milrinone; Mitral Valve; Pilot Projects; Simendan | 2019 |
The Effect of Inhaled Milrinone Versus Inhaled Levosimendan in Pulmonary Hypertension Patients Undergoing Mitral Valve Surgery.
Topics: Double-Blind Method; Humans; Hypertension, Pulmonary; Milrinone; Mitral Valve; Pilot Projects; Simendan | 2019 |
Inhaled iloprost plus levosimendan to decompensate right heart failure due to chronic thromboembolic pulmonary hypertension.
Topics: Administration, Inhalation; Critical Care; Diuretics; Furosemide; Heart Failure; Humans; Hydrazones; Hypertension, Pulmonary; Iloprost; Male; Middle Aged; Pyridazines; Simendan; Thromboembolism; Vasodilator Agents; Ventricular Dysfunction, Right | 2013 |
Levosimendan reverted severe pulmonary hypertension in one patient on waiting list for heart transplantation.
Topics: Female; Heart Transplantation; Humans; Hydrazones; Hypertension, Pulmonary; Pyridazines; Simendan; Vasodilator Agents; Waiting Lists; Young Adult | 2013 |
[Nitrid oxide, levosimendan and sildenafile in a patient with right ventricle dysfunction and severe pulmonary hypertension after cardiac surgery].
Topics: Aged; Aorta; Dobutamine; Drug Synergism; Drug Therapy, Combination; Female; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Hypertension, Pulmonary; Nitric Oxide; Norepinephrine; Postoperative Complications; Pyridazines; Sildenafil Citrate; Simendan; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Right | 2014 |
Levosimendan in lung transplant recipients with difficult weaning from ECMO.
Topics: Adult; Extracorporeal Membrane Oxygenation; Humans; Hydrazones; Hypertension, Pulmonary; Lung Transplantation; Male; Pyridazines; Simendan; Transplant Recipients; Vasodilator Agents; Ventilator Weaning | 2015 |
Levosimendan for bridging in a pediatric patient with Alström syndrome awaiting heart-lung transplantation.
Topics: Abnormalities, Multiple; Adolescent; Cardiomyopathy, Dilated; Cardiotonic Agents; Cell Cycle Proteins; Heart-Lung Transplantation; Humans; Hydrazones; Hypertension, Pulmonary; Male; Proteins; Pyridazines; Simendan; Syndrome; Treatment Outcome; Waiting Lists | 2008 |
Levosimendan and severe pulmonary hypertension during open heart surgery.
Topics: Cardiac Surgical Procedures; Female; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Hypertension, Pulmonary; Middle Aged; Pyridazines; Simendan; Time Factors; Treatment Outcome; Vasodilator Agents | 2008 |
Levosimendan is not effective in reducing pulmonary pressures in patients with idiopathic pulmonary arterial hypertension: report of two cases.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Echocardiography; Female; Humans; Hydrazones; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Artery; Pyridazines; Simendan; Treatment Failure; Vasodilator Agents | 2009 |
Superiority of levosimendan over dobutamine in right ventricle failure.
Topics: Cardiotonic Agents; Critical Care; Critical Illness; Dobutamine; Female; Heart Function Tests; Humans; Hydrazones; Hypertension, Pulmonary; Intensive Care Units; Male; Myocardial Infarction; Prognosis; Pyridazines; Shock, Cardiogenic; Simendan; Survival Rate; Treatment Outcome; Vascular Resistance; Ventricular Dysfunction, Right | 2010 |
Can pulmonary artery hypertension be attributed to levosimendan? A problematic based on a patient's case.
Topics: Aged; Aortic Valve Stenosis; Blood Pressure; Cardiotonic Agents; Coronary Artery Bypass; Coronary Artery Disease; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Hypertension, Pulmonary; Pulmonary Artery; Pyridazines; Simendan | 2010 |
Levosimendan and pulmonary hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Hypertension, Pulmonary; Pulmonary Artery; Pyridazines; Simendan; Treatment Outcome; Vasodilator Agents; Ventricular Function | 2010 |
No beneficial effects of levosimendan in acute porcine endotoxaemia.
Topics: Animals; Blood Pressure; Cardiotonic Agents; Cytokines; Echocardiography; Endotoxemia; Heart Function Tests; Hemodynamics; Hydrazones; Hypertension, Pulmonary; Kidney Function Tests; Lactic Acid; Lipopolysaccharides; Liver Function Tests; Pulmonary Circulation; Pyridazines; Regional Blood Flow; Sample Size; Simendan; Swine; Water-Electrolyte Balance | 2011 |
Levosimendan in two neonates with ischemic heart failure and pulmonary hypertension.
Topics: Cardiotonic Agents; Female; Heart Failure; Humans; Hydrazones; Hypertension, Pulmonary; Infant, Newborn; Male; Myocardial Ischemia; Pyridazines; Simendan; Treatment Outcome | 2012 |
Inotropic support in the NICU: ever more compounds in search of guidance? Commentary on J. Esch et al.: differential hemodynamic effects of levosimendan in a porcine model of neonatal hypoxia-reoxygenation (Neonatology 2012;101:192–200) and M.P. De Caroli
Topics: Animals; Cardiac Output; Cardiotonic Agents; Female; Fetal Hypoxia; Heart Failure; Humans; Hydrazones; Hypertension, Pulmonary; Male; Myocardial Ischemia; Oxygen; Pyridazines; Simendan; Swine | 2012 |
Levosimendan attenuates hypoxia-induced pulmonary hypertension in a porcine model.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Female; Heart Rate; Hydrazones; Hypertension, Pulmonary; Hypoxia; Oxygen Consumption; Pyridazines; Simendan; Swine; Time Factors; Vascular Resistance | 2012 |
Novel strategies for the management of right ventricular failure with pulmonary hypertension.
Topics: Adult; Anti-Bacterial Agents; Antihypertensive Agents; Ascites; Cardiotonic Agents; Combined Modality Therapy; Disease Progression; Drug Therapy, Combination; Echocardiography; Electrocardiography; Epoprostenol; Female; Humans; Hydrazones; Hypertension, Pulmonary; Paracentesis; Pyridazines; Simendan; Ventricular Dysfunction, Right | 2012 |
[Possibilities of using levosimendan in patients with idiopathic pulmonary hypertension].
Topics: Adult; Blood Pressure; Cardiotonic Agents; Echocardiography; Epinephrine; Exercise Test; Familial Primary Pulmonary Hypertension; Female; Follow-Up Studies; Heart Rate; Humans; Hydrazones; Hypertension, Pulmonary; Infusions, Intravenous; Male; Natriuretic Peptide, Brain; Norepinephrine; Peptide Fragments; Pyridazines; Severity of Illness Index; Simendan; Ventricular Dysfunction, Right; Young Adult | 2012 |
[Levosimendan-long-term inodilation in an infant with myocardial infarction].
Topics: Cardiac Output, Low; Cardiotonic Agents; Coronary Stenosis; Coronary Vessel Anomalies; Echocardiography, Doppler; Electrocardiography, Ambulatory; Humans; Hydrazones; Hypertension, Pulmonary; Infant; Infant, Newborn; Long-Term Care; Male; Myocardial Infarction; Postoperative Complications; Pulmonary Artery; Pulmonary Wedge Pressure; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2004 |
End-stage heart failure with pulmonary hypertension: levosimendan to evaluate for heart transplantation alone versus combined heart-lung transplantation.
Topics: Adolescent; Cardiac Output, Low; Cardiotonic Agents; Heart Transplantation; Heart-Lung Transplantation; Humans; Hydrazones; Hypertension, Pulmonary; Male; Pyridazines; Simendan | 2004 |
Levosimendan in severe right ventricular failure following mitral valve replacement.
Topics: Adult; Cardiopulmonary Bypass; Female; Humans; Hydrazones; Hypertension, Pulmonary; Mitral Valve; Mitral Valve Stenosis; Postoperative Complications; Pyridazines; Simendan; Ventricular Dysfunction, Right | 2006 |
A new horizon in the treatment of right ventricular failure and pulmonary hypertension associated with acute respiratory distress syndrome?
Topics: Humans; Hydrazones; Hypertension, Pulmonary; Pyridazines; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome; Shock, Septic; Simendan; Vasodilator Agents; Ventricular Dysfunction, Right | 2006 |
Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure.
Topics: Animals; Cardiotonic Agents; Dobutamine; Dogs; Heart Failure; Hydrazones; Hypertension, Pulmonary; Prospective Studies; Pulmonary Artery; Pulmonary Circulation; Pyridazines; Random Allocation; Simendan; Ventricular Dysfunction, Right | 2006 |
Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Hydrazones; Hypertension, Pulmonary; Myocardial Contraction; Pulmonary Artery; Pyridazines; Simendan; Stroke Volume; Swine; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Right; Ventricular Function, Right | 2007 |
Dear levosimendan, the right ventricle will thank you!
Topics: Animals; Cardiotonic Agents; Humans; Hydrazones; Hypertension, Pulmonary; Myocardial Contraction; Pulmonary Wedge Pressure; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Swine; Vasodilator Agents; Ventricular Dysfunction, Right; Ventricular Function, Right | 2007 |
Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure.
Topics: Acute Disease; Animals; Cardiac Output; Cardiotonic Agents; Hydrazones; Hypertension, Pulmonary; Pulmonary Circulation; Pulmonary Embolism; Pyridazines; Random Allocation; Respiration; Simendan; Swine; Ventricular Dysfunction, Right | 2007 |
Management of pulmonary hypertension in the intensive care unit.
Topics: Cardiotonic Agents; Critical Care; Humans; Hydrazones; Hypertension, Pulmonary; Pyridazines; Simendan; Ventricular Dysfunction, Right | 2008 |
Therapies for heart failure: a report from the Heart Failure Congress 2007.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Diuretics; Genetic Therapy; Heart Failure; Heart Transplantation; Hormone Replacement Therapy; Humans; Hydrazones; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Mineralocorticoid Receptor Antagonists; Pyridazines; Simendan | 2007 |